United States· US:69396-021_521c3e73-7f54-8282-e063-6294a90a8c72

Zinc Oxide 20%

A medicinal product containing zinc oxide, registered in United States by Trifecta Pharmaceuticals USA.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedZinc Oxide 20%ATC—REGISTER NO.US:69396-021_521c3e73…PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Zinc Oxide
Manufacturer
Trifecta Pharmaceuticals USA
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    6939602154
    1 JAR in 1 JAR (69396-021-54) / 454 g in 1 JAR

Regulatory notes

UNII (FDA substance ID)
SOI2LOH54Z
ZINC OXIDE
RxCUI 11423
DailyMed SPL labels
1 version tracked

Same medicine, other countries

Zinc oxide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All zinc oxide products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Labisan, Zink Aguettant
  • Belgium · Unguentum, Zinc Aguettant
  • Germany · Biolectra, Cefazink
  • Denmark · Zipzoc
  • Spain · Pasta Lassar Imba
  • Finland · Zipzoc
  • France · Effizinc, Oligosol
  • United Kingdom (Northern Ireland) · Solvazinc, Zinc & Castor Oil L.C.M
  • Greece · Zincalto, Zinctin
  • Ireland · Caldease, Zinc Ovelle
  • Iceland · Wilzin
  • Italy · Zinco Ossido Marco Viti, Zinco Ossido Nova Argentia
  • Liechtenstein · Wilzin
  • Luxembourg · Cefazink, Oligosol
  • Latvia · Cinka Rff
  • Netherlands · Daro Zinkzalf, Zinkolie
  • Norway · Wilzin
  • Poland · Maść Cynkowa,, Maść Z Tlenkiem Cynku
  • Portugal · Halibut, Lassadermil
  • Sweden · Zipzoc
  • Slovakia · Tekutý Púder

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cae84c83-32c8-4ac6-acd2-62b3964b0379
GET /v1/drugs/cae84c83-32c8-4ac6-acd2-62b3964b0379?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "SOI2LOH54Z",
    "rxcui": "11423",
    "inchikey": "RNWHGQJWIACOKP-UHFFFAOYSA-N",
    "display_name": "ZINC OXIDE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "TOPICAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "63b551fc-7d16-c099-e053-2a91aa0a5f2c": {
      "match": "brand_token",
      "title": "ZINC OXIDE 20% (ZINC OXIDE) OINTMENT [TRIFECTA PHARMACEUTICALS USA]",
      "spl_version": "7",
      "published_date": "2026-05-20"
    }
  },
  "productid": "69396-021_521c3e73-7f54-8282-e063-6294a90a8c72",
  "productndc": "69396-021",
  "dosage_form": "OINTMENT",
  "dea_schedule": null,
  "product_type": "HUMAN OTC DRUG",
  "substance_name": "ZINC OXIDE",
  "proprietary_name": "Zinc Oxide 20%",
  "active_ingred_unit": "g/g",
  "application_number": "M016",
  "marketing_category": "OTC MONOGRAPH DRUG",
  "nonproprietary_name": "Zinc Oxide",
  "start_marketing_date": "20190701",
  "active_numerator_strength": ".2"
}

See everything about zinc oxide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.